Previous Close | 272.88 |
Open | 271.15 |
Bid | 268.97 x 100 |
Ask | 269.36 x 100 |
Day's Range | 267.03 - 274.00 |
52 Week Range | 205.93 - 279.98 |
Volume | |
Avg. Volume | 526,124 |
Market Cap | 11.941B |
Beta (5Y Monthly) | 0.54 |
PE Ratio (TTM) | 12.74 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.